ACUTAAS vs KPL: Stock Comparison

Acutaas Chemicals Limited vs Kwality Pharmaceuticals Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Acutaas Chemicals Limited is the larger company by market capitalisation. Acutaas Chemicals Limited shows a higher ROE, a higher dividend yield and faster revenue growth, while Kwality Pharmaceuticals Ltd shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Acutaas Chemicals Limited and Kwality Pharmaceuticals Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ACUTAAS is more favourable on 10 of 13 scored metrics and KPL on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ACUTAAS is the larger company
₹26,480 Cr vs ₹2,692 Cr
P/E Ratio
KPL has a lower P/E
39.83x vs 70.15x
P/B Ratio
KPL has a lower P/B
8.09x vs 16.38x
EPS
KPL has higher earnings per share
₹64.9 vs ₹36.04
Dividend Yield
ACUTAAS has a higher dividend yield
0.05% vs 0%
Revenue Growth (TTM YoY)
ACUTAAS has faster revenue growth
40.3% vs 0%
EPS Growth (TTM YoY)
ACUTAAS has faster EPS growth
105.6% vs 0%
Qtr Sales Growth
ACUTAAS has stronger quarterly sales growth
40.3% vs 35.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricACUTAASKPL
SectorHealthcare
IndustryPharmaceuticals

Price

MetricACUTAASKPL
Live Price₹3,297.7₹2,590.4
Day Change-2.08%-4.34%
Volume8.38 L26,342
52-Week High₹3,740₹2,890.3
52-Week Low₹1,125₹1,561
Distance from 52W High-11.83%-10.38%

Valuation

MetricACUTAASKPL
Market Cap₹26,480 Cr₹2,692 Cr
P/E Ratio70.15x39.83x
P/B Ratio16.38x8.09x
EPS₹36.04₹64.9
Book Value₹201.93₹320
Dividend Yield0.05%0%

Growth

MetricACUTAASKPL
Revenue Growth (TTM YoY)40.3%0%
EPS Growth (TTM YoY)105.6%0%
Qtr Sales Growth40.3%35.8%
Qtr Profit Growth111%74.6%

Profitability & Leverage

MetricACUTAASKPL
ROE24%22.8%
ROCE31.6%24.2%
Net Margin26.6%13.39%
Operating Margin35.9%23.5%
Debt to Equity0.02x0.39x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricACUTAASKPL
Promoter Holding32.66%54.87% 0.04 pp
FII Holding21.61% 2.13 pp2.79% 2.29 pp
DII Holding19.56% 0.04 pp0.36% 0.03 pp
Public Holding26.16% 2.08 pp41.98% 2.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Acutaas Chemicals Limited and Kwality Pharmaceuticals Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.